ZHONGHENG GROUP(SH:600252)2024-12-13 07:35Group 1: Share Buyback Progress - As of September 27, 2024, the company has completed its share buyback plan, repurchasing a total of 122,928,437 shares, which accounts for 3.5616% of the total share capital [1] - The total amount spent on the buyback is RMB 279,110,029.03, excluding transaction fees [1] - Of the repurchased shares, 81,952,291 shares (approximately 66.7%) will be canceled to reduce the registered capital [2] Group 2: Response to Aging Population - The company is focusing on cardiovascular diseases while addressing unmet clinical needs and potential market development [2] - Key product "Xue Tong Tong" is undergoing technological and quality improvements to maintain its competitive edge [2] - The company is also developing functional foods and health drinks based on the concept of "food as medicine" to expand into emerging channels [2] Group 3: Recent Performance Overview - For the period of January to September 2024, the company achieved operating revenue of RMB 1.122 billion and a net profit attributable to shareholders of RMB 19.27 million [2] - The company is enhancing internal development momentum through reforms in key areas and focusing on market expansion and marketing strategy optimization [2] - Further operational details can be found in the company's Q3 2024 report disclosed on October 30, 2024 [2]